Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference

Company Overview - Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies [2] - The company's lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody aimed at treating multiple solid tumors [2] Upcoming Events - Bronson Crouch, the Chief Executive Officer of Instil Bio, will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 4:20 PM ET [1] - A live webcast of the presentation will be available through a specified weblink [1]